meloxicam

FDA Drug Profile — meloxicam, MELOXICAM, XIFYRM

meloxicam is listed in the FDA National Drug Code directory with 91 NDC codes, marketed under brand names including meloxicam, MELOXICAM, XIFYRM. Available dosage forms: tablet, powder, injection.

Drug details

Generic Name
meloxicam
Brand Names
meloxicam, MELOXICAM, XIFYRM
Application Number
ANDA077927
Sponsor
PD-Rx Pharmaceuticals, Inc.
NDC Codes
91
Dosage Forms
TABLET, POWDER, INJECTION
Routes
ORAL, INTRAVENOUS
Active Ingredients
MELOXICAM

Indications and Usage

1 INDICATIONS AND USAGE Meloxicam is a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) (1.1) Rheumatoid Arthritis (RA) (1.2) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg (1.3) 1.1 Osteoarthritis (OA) Meloxicam is indicated for relief of the signs and symptoms of osteoarthritis [ see Clinical Studies (14.1)]. 1.2 Rheumatoid Arthritis (RA) Meloxicam is indicated for relief of the signs and symptoms of rheumatoid arthritis [ see Clinical Studies (14.1) ]. 1.3 Juvenile Rheumatoid Arthritis (JRA) Pauciarticular and Polyarticular Course Meloxicam is indicated for relief of the signs and symptoms of pauciarticular or polyarticular course Juvenile Rheumatoid Arthritis in patients who weigh ≥ 60 kg [ see Dosage and Administration ( 2.4 ) and Clinical Studies (14.2) ].

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.